HFA
ARKG icon

Hoover Financial Advisors’s ARK Genomic Revolution ETF ARKG Stock Holding History

Hoover Financial Advisors’s Portfolio ARKG Stock Details ARKG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		$160K Buy
1,731
+273
+19% +$23.2K 0.03% 156
2021
Q1 		$112K Buy
+1,458
New +$145K 0.02% 178

Other funds holding ARKG

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
SDH
Sloy Dahl & Holst Vancouver, Washington $728M AUM 37.66% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Hoover Financial Advisors's ARKG Position: Q2 2021 in Review

Hoover Financial Advisors increased its ARK Genomic Revolution ETF (ARKG) stake by 19% in Q2 2021, buying an estimated $23.2K and bringing the position to 1,731 shares worth $160K. The position accounts for 0.03% of the portfolio, ranked #156.

Hoover Financial Advisors first reported a position in ARKG in Q1 2021 and has held it in 2 quarters since. 513 funds tracked by Wall St. Rank hold ARKG as of Q2 2021.

  • Hoover Financial Advisors held 1,731 shares of ARK Genomic Revolution ETF worth $160K as of Q2 2021.
  • Hoover Financial Advisors bought 273 ARK Genomic Revolution ETF shares in Q2 2021, an estimated $23.2K.
  • ARK Genomic Revolution ETF made up 0.03% of Hoover Financial Advisors's portfolio in Q2 2021, its #156 holding.
  • Hoover Financial Advisors first reported a position in ARK Genomic Revolution ETF in Q1 2021 and has held it in 2 quarters since.
  • 513 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q2 2021.

Based on Hoover Financial Advisors's 13F filing for Q2 2021, filed 28 Jul 2021.